Tilia Fiduciary Partners’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-929
Closed -$148K 160
2023
Q2
$148K Buy
929
+2
+0.2% +$323 0.13% 106
2023
Q1
$147K Buy
927
+1
+0.1% +$150 0.14% 111
2022
Q4
$130K Sell
926
-98
-10% -$13.9K 0.12% 120
2022
Q3
$131K Sell
1,024
-303
-23% -$43.7K 0.13% 115
2022
Q2
$191K Buy
1,327
+2
+0.2% +$286 0.18% 97
2022
Q1
$184K Sell
1,325
-138
-9% -$21.1K 0.16% 105
2021
Q4
$255K Buy
+1,463
New +$244K 0.2% 93

Other funds holding CLX

Tilia Fiduciary Partners's CLX Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of Clorox (CLX) in Q3 2023, closing a stake of 929 shares — an estimated $148K sold.

Tilia Fiduciary Partners first reported a position in CLX in Q4 2021 and held it in 7 quarters. The position peaked at $255K in Q4 2021. 1,064 funds tracked by Wall St. Rank hold CLX as of Q3 2023.

  • Tilia Fiduciary Partners reported no remaining Clorox position as of Q3 2023 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 929 Clorox shares in Q3 2023, an estimated $148K.
  • Tilia Fiduciary Partners first reported a position in Clorox in Q4 2021 and held it in 7 quarters.
  • Tilia Fiduciary Partners's Clorox position peaked at $255K in Q4 2021.
  • 1,064 funds tracked by Wall St. Rank held Clorox as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.